Ten unfavorable sera were obtained from healthy controls living in sand flyCfree regions. Such antibodies were specific for Dsg1 and Dsg3 and were not the result of cross-reactivity IQ-1 to PpSP32. In this study, we exhibited for the first time to our knowledge a specific binding between PpSP32 and Dsg1 and Dsg3, which might underlie the triggering of anti-Dsg antibodies in patients exposed to sand fly bites. We also confirmed the development of specific anti-Dsg1 and -Dsg3 antibodies in vivo after PpSP32 immunization in mice. Collectively, our results provide evidence that environmental factors, such as the exposure to bites, can trigger the development of autoimmune antibodies. Keywords: Autoimmunity, Immunology Keywords: Autoimmune diseases, Tolerance A specific binding between salivary protein PpSP32 and desmogleins may trigger anti-Dsg antibodies in patients exposed to sand fly bites. Introduction Pemphigus is an organ-specific autoimmune bullous disease characterized by keratinocyte detachment, resulting from the presence of autoantibodies targeting 2 major desmoglein (Dsg) proteins, Dsg1 and Dsg3, approximately 160 and 130 kDa, respectively (1). Much like other autoimmune diseases, pemphigus is the consequence of the conversation between predisposing genetic factors and inducing environmental triggers. However, events triggering the development of anti-Dsg antibodies are still largely unknown. Tunisian pemphigus shares clinical and epidemiological features with Fogo Selvagem, an endemic form of pemphigus foliaceous in Brazil. Several findings point to the involvement of vector-borne parasite infections, particularly leishmaniasis, in the pathogenesis of endemic pemphigus (2, 3). In Tunisia, zoonotic cutaneous leishmaniasis (ZCL) attributed to ((was exhibited in patients with pemphigus compared with healthy subjects (5). Such antibodies are essentially composed of the IgG4 isotype and directed against the generally recognized salivary proteins of bites may, therefore, be a possible etiologic IQ-1 link to pemphigus in Tunisia. Here, we demonstrate that during the bite of [8]) as a protein control for PpSP32). A specific and dose-dependent conversation between rPpSP32 and Dsg1 and Dsg3 was observed (Physique 3). No conversation was observed between rPpSP32 and BP180, desmocollin 3, or desmoplakin or between CFP32 and the Dsgs (Physique 3). Open in a separate window Physique 3 ELISA showing a specific and IQ-1 dose-dependent conversation between PpSP32 and the proteins Dsg1 and Dsg3.The ELISA plates were coated with the recombinant proteins Dsg1 and Dsg3 or other epidermal proteins; BP180, desmocollin 3 and desmoplakin and then incubated with a decreasing concentration of rPpSP32, the protein of interest or CFP32, a control protein. The plates were then incubated in the presence of human sera with anti-PpSP32 or -CFP32 antibodies. The results are representative of 3 impartial experiments. Significant differences were found between the different PpSP32 concentrations for Dsg1 and Dsg3 (= 0.006 and = 0.008 between the condition 2 g/mL and 0.0002 g/mL for Dsg1 and Dsg3, respectively). For the control proteins, no significant difference was obtained while decreasing the concentration of PpSP32 (> 0.05). Mice immunized with PpSP32 develop antibodies specific for Dsg1 and Dsg3. To confirm in vivo the implication of PpSP32 in the development of antibodies linked to pemphigus, Swiss Webster mice were immunized intradermally with 2 g rPpSP32 over 4 months. The sera were recovered every 15 days and tested for the presence of both anti-PpSP32 antibodies and anti-mouse Dsg1 and Dsg3 antibodies. As shown in Physique 4A, mice immunized with rPpSP32 developed, as expected, anti-PpSP32 antibodies at high titers. Interestingly, such mice also developed anti-Dsg1 and -Dsg3 antibodies at high levels that were significant (< 0.05) from your sixth sampling (at day 90) to the eighth sampling (at day 120) when compared with those at the first sampling after immunization. Western blot analyses confirmed the development of such specific antibodies (Physique 4B). When tested by immunofluorescence on monkey esophagus and mouse tail and tongue, such antibodies gave the characteristic pattern of intercellular material staining, further confirming recognition of the Dsgs compared with tissues tested with preimmune sera (Physique 4C). Open in a separate windows Physique 4 Development of anti-Dsg1 and Rabbit Polyclonal to H-NUC -Dsg3 antibodies in mice immunized with PpSP32.Mice were immunized intradermally with 2 g rPpSP32 twice weekly over 30 days and then once per week for 90 days. (A) The sera, recovered every 15 days (samples 1C8) were tested by ELISA to detect total IgG antibodies anti-PpSP32, -Dsg1, and -Dsg3. *< 0.05. Students IQ-1 test when compared with sample 1. For anti-Dsg1 antibodies, = 0.009, = 0.01, and = 0.01 at the sixth, seventh, and eighth sample, respectively. For anti-Dsg3 antibodies, = 0.008, = 0.025, and = 0.0016 at the sixth, seventh, and eighth sample, respectively. (B) Sera recovered at day 120 (sample 8) were tested by Western blot against rPpSP32, partial Dsg1 (rDsg1, MW 77 KDa), or partial Dsg3 (rDsg3, MW 79 KDa). The result is usually representative of 3 impartial experiments. (C) Preimmune sera and sera recovered at day 120 (sample 8) IQ-1 were tested by immunofluorescence on monkey.